Robert E. Farrell, Jr. Insider Information
Robert E. Farrell Jr., CPA
is the Senior Vice President of Finance/Operations and Chief Accounting Officer at Morphic Therapeutic Inc. and was part of the initial company formation in June 2015. Prior to joining Morphic Therapeutic, he served as Vice President of Finance and Administration and Treasurer of Genocea Biosciences from 2009 to 2015. Before that, he held senior level financial positions at Oscient Pharmaceuticals, Magen Biosciences and NeoGenesis Pharmaceuticals, Inc., where he directed companies through multiple private financings, acquisitions and several public offerings. Mr. Farrell is a licensed certified public accountant and holds a B.S. degree in accounting from Bentley University.
What is Robert E. Farrell, Jr.'s net worth?
The estimated net worth of Robert E. Farrell, Jr. is at least $1.17 million as of June 16th, 2021. Mr. Farrell, Jr. owns 18,234 shares of Morphic stock worth more than $1,174,452 as of September 26th. This net worth estimate does not reflect any other investments that Mr. Farrell, Jr. may own. Learn More.
How do I contact Robert E. Farrell, Jr.?
The corporate mailing address for Mr. Farrell, Jr. and other Morphic executives is 35 Gatehouse Drive A2, Waltham MA, 02451. Morphic can also be reached via phone at (781) 996-0955.
Has Robert E. Farrell, Jr. been buying or selling shares of Morphic?
Within the last three months, Robert E. Farrell, Jr. has sold $198,215.00 in Morphic stock. Most recently, Robert E. Farrell, Jr. sold 3,049 shares of the business's stock in a transaction on Monday, September 13th. The shares were sold at an average price of $65.01, for a transaction totalling $198,215.49.
Are insiders buying or selling shares of Morphic?
During the last twelve months, Morphic insiders bought shares 5 times. They purchased a total of 206,927 shares worth mmore than $12,382,649.70. During the last twelve months, insiders at the sold shares 87 times. They sold a total of 1,006,233 shares worth mmore than $47,028,888.88. The most recent insider tranaction occured on September, 16th when Peter Linde Insider bought 4,000 shares worth more than $266,040.00. Insiders at Morphic own 31.4 % of the company.
Information on this page was last updated on 9/16/2021.
Robert E. Farrell, Jr. Insider Trading History at Morphic
|Transaction Date||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Shares Held After Transaction||Details|
Morphic Company Overview
Morphic Holding, Inc. operates as a biopharmaceutical company, which engages in the research and development of oral small-molecule integrin therapeutics. It operates a Morphic integrin technology platform, MInT platform, to create a broad pipeline of programs across a variety of therapeutic areas. The company was founded by Timothy A. Springer in August 2014 and is headquartered in Waltham, MA.
50 Day Range
2 Week Range